These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 23971925)
1. [APOBEC3 hypermutations in HIV-1 infected cases in Turkey]. Sayan M; Simşek F; Ceran N; Dokuzoğuz B; Eraksoy H Mikrobiyol Bul; 2013 Jul; 47(3):482-92. PubMed ID: 23971925 [TBL] [Abstract][Full Text] [Related]
2. High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients. Bertine M; Charpentier C; Visseaux B; Storto A; Collin G; Larrouy L; Damond F; Matheron S; Brun-Vézinet F; Descamps D; AIDS; 2015 Apr; 29(7):779-84. PubMed ID: 25985400 [TBL] [Abstract][Full Text] [Related]
3. Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals. Neogi U; Shet A; Sahoo PN; Bontell I; Ekstrand ML; Banerjea AC; Sonnerborg A J Int AIDS Soc; 2013 Feb; 16(1):18472. PubMed ID: 23443042 [TBL] [Abstract][Full Text] [Related]
4. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections. Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112 [TBL] [Abstract][Full Text] [Related]
5. [Molecular Epidemiological Analysis of HIV-1 pol Gene Sequences Isolated in Istanbul, Turkey]. Sayan M; Kumbasar Karaosmanoğlu H; Mete B; Gündüz A; Aydın O; Yemişen M; Uzun N; Tabak F Mikrobiyol Bul; 2013 Jan; 47(1):87-97. PubMed ID: 23390906 [TBL] [Abstract][Full Text] [Related]
6. Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals. Fourati S; Malet I; Binka M; Boukobza S; Wirden M; Sayon S; Simon A; Katlama C; Simon V; Calvez V; Marcelin AG AIDS; 2010 Sep; 24(15):2313-21. PubMed ID: 20729708 [TBL] [Abstract][Full Text] [Related]
7. Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants. Noguera-Julian M; Cozzi-Lepri A; Di Giallonardo F; Schuurman R; Däumer M; Aitken S; Ceccherini-Silberstein F; D'Arminio Monforte A; Geretti AM; Booth CL; Kaiser R; Michalik C; Jansen K; Masquelier B; Bellecave P; Kouyos RD; Castro E; Furrer H; Schultze A; Günthard HF; Brun-Vezinet F; Metzner KJ; Paredes R; Clin Microbiol Infect; 2016 Feb; 22(2):191-200. PubMed ID: 26482266 [TBL] [Abstract][Full Text] [Related]
8. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers. Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G. Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650 [TBL] [Abstract][Full Text] [Related]
10. Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count. Bizinoto MC; Yabe S; Leal É; Kishino H; Martins Lde O; de Lima ML; Morais ER; Diaz RS; Janini LM BMC Infect Dis; 2013 Apr; 13():173. PubMed ID: 23578255 [TBL] [Abstract][Full Text] [Related]
11. [Molecular characterization of complex recombinant HIV-1 CRF06_cpx subtype detected in Turkey]. Sayan M; Kaptan F; Ormen B; Türker N Mikrobiyol Bul; 2014 Jan; 48(1):160-7. PubMed ID: 24506727 [TBL] [Abstract][Full Text] [Related]
12. APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz. Covino DA; Purificato C; Catapano L; Galluzzo CM; Gauzzi MC; Vella S; Lefebvre E; Seyedkazemi S; Andreotti M; Fantuzzi L Front Immunol; 2018; 9():1839. PubMed ID: 30135687 [TBL] [Abstract][Full Text] [Related]
13. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load. Reddy K; Winkler CA; Werner L; Mlisana K; Abdool Karim SS; Ndung'u T; AIDS; 2010 Jan; 24(2):195-204. PubMed ID: 19996938 [TBL] [Abstract][Full Text] [Related]
14. ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response. Scagnolari C; Monteleone K; Selvaggi C; Pierangeli A; D'Ettorre G; Mezzaroma I; Turriziani O; Gentile M; Vullo V; Antonelli G Immunobiology; 2016 Feb; 221(2):282-90. PubMed ID: 26563749 [TBL] [Abstract][Full Text] [Related]
15. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya. Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281 [TBL] [Abstract][Full Text] [Related]
16. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases]. Yalçınkaya T; Köse S Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654 [TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya. Land AM; Ball TB; Luo M; Pilon R; Sandstrom P; Embree JE; Wachihi C; Kimani J; Plummer FA J Virol; 2008 Aug; 82(16):8172-82. PubMed ID: 18550667 [TBL] [Abstract][Full Text] [Related]
18. Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors. Gandhi SK; Siliciano JD; Bailey JR; Siliciano RF; Blankson JN J Virol; 2008 Mar; 82(6):3125-30. PubMed ID: 18077705 [TBL] [Abstract][Full Text] [Related]
19. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count. Cho SJ; Drechsler H; Burke RC; Arens MQ; Powderly W; Davidson NO J Virol; 2006 Feb; 80(4):2069-72. PubMed ID: 16439564 [TBL] [Abstract][Full Text] [Related]
20. Absence of Cano-Ortiz L; Maletich Junqueira D; Comerlato J; Zani A; Santos Costa C; Michel Roehe P; Franco AC Viruses; 2018 May; 10(6):. PubMed ID: 29857485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]